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In this issue of Neuron, Han and colleagues bring optogenetic methods into use in nonhuman primates by
demonstrating the feasibility of achieving cell-type-specific photoactivation of macaque neocortical
neurons. The use of optogenetic approaches in nonhuman primates promises to revolutionize our under-
standing of the neural circuitry that mediates complex cognitive functions.Major scientific breakthroughs often stem
from key technological advances. For
example, the development of gene target-
ing techniques has revolutionized biology
by providing a set of tools that can be
used to visualize, measure, and systemat-
ically change the spatiotemporal
processes that define living systems.
Within neurobiology, these techniques
havebeenused tostudy thedetailed struc-
ture and function of neural circuits. In
recent years, new optogenetic methods
havemade it possible to target andmodu-
late the activity of genetically distinct
groups of neurons with pulses of light
(Luo et al., 2008; Zhang et al., 2007). Opto-
genetic methods often involve cell-type-
specific expression of a light-responsive
channel—channelrhodopsin-2 (ChR2),
a transmembrane protein derived from
the green algae Chlamydomonas. ChR2
contains a chromophore which, upon
absorption of blue light, undergoes
a conformational change that causes the
transmembrane channel to open. The
influx of cations caused by the opening of
the channel leads to neuronal depolariza-
tion and generation of action potentials.
The great advantage of this approach is
that ChR2 can be expressed in selected
types of neurons, allowing one to establish
a causal link between their activity and
resulting changes in the properties of the
system within which they are embedded,
such as changes in physiological proper-
ties or behavior (Adamantidis et al., 2007).
Viral methods have previously been used
to enable suppression of neuronal activity
in themonkey (Tan et al., 2006), andphoto-
activation of neurons expressingChR2has
successfully been used to probe neural
circuits not only in vitro (Boyden et al.,
2005) and in invertebrate animals (Nagel
et al., 2005), but also in the brains of awakebehaving rodents (Zhang et al., 2007).
Photoactivation has not, however, been
used in the awake primate, until now.
Han and colleagues (2009) made
stereotactic injections of lentivirus
carrying the gene for ChR2, expressed
under the CaMKII promoter, in macaque
frontal cortex. They then used histological
techniques to demonstrate convincingly
that the procedure resulted in ChR2
expression predominantly in excitatory
pyramidal neurons. It is worth noting that
cell-specific targeting of neurons achieved
in this study is not likely due solely to the
use of a cell-specific promoter but also to
the use of lentivirus, which tends to infect
mainly excitatory pyramidal neurons (Na-
thanson et al., 2009). Using in vivo optical
stimulation combined with electrophysio-
logical recordings, the authors showed
that it is possible to influence the activity
of neurons in the infected area with milli-
second temporal precision.
Although ChR2 was expressed in
excitatory pyramidal neurons, Han and
colleagues (2009) found that the activity
of many neurons was suppressed fol-
lowing exposure to light. In addition, even
neurons that increased their firing rates
during photostimulation exhibited re-
duced levels of activity immediately after
light cessation. The authors concluded
that these reductions in firing rate likely re-
sulted from recruitment of inhibitory inter-
neurons that were activated by ChR2
expressing pyramidal neurons. This is
consistent with previous studies employ-
ing optogenetic techniques to target pyra-
midal neurons in rodents and underscores
the importance of considering the effects
of targeted neuronal activation within the
context of the broader neural network.
One possible concern when using op-
togenetic techniques in animal models isNeurothe possibility that the technique might
damage the very circuitry to be studied.
Therefore, Han and colleagues (2009)
took pains to test whether viral infection,
ChR2 expression, or photostimulation
resulted either in direct tissue damage or
an immune response. They found that it
did not. Repeated electrophysiological
recordings and subsequent histological
examination of the infected tissue did
not show signs of abnormalities in neural
activity or cellular architecture. They
also found no evidence of a productive
immune response to ChR2. Taken to-
gether, their findings demonstrate the
safety and efficiency of the optogenetic
technique in primates over a period of
months.
Successful photostimulation of a class
of neurons in the rhesus macaque brain
constitutes a substantial step forward
because it opens the door to the use of op-
togenetic approaches todissect theneural
circuits underlying human cognitive func-
tions that arebest studied in thenonhuman
primate model. The nonhuman primate is
advantageous for several reasons. First,
the macaque brain has been the subject
of investigation for decades and is con-
sequently one of the most well-studied
model systems in neurobiology. Within
the visual system alone, over thirty distinct
visual areas have been identified and their
anatomical interconnections thoroughly
mapped (Felleman and Van Essen, 1991).
The anatomy and functional connectivity
of the local cortical circuits within some
areas have been studied in exquisite detail
(Callaway, 1998). This wealth of knowl-
edge about the macaque brain has
enabled researchers to pose highly refined
questions about perception and cognition.
Second, the rhesus macaque can be
trained to perform behavioral tasks similarn 62, April 30, 2009 ª2009 Elsevier Inc. 159
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abilities. It has thus been possible, using
conventional electrophysiological and
imaging techniques, to identify and des-
cribe in depth the changes in neuronal
response properties that accompany
cognitive processes such as attention,
decision making, and memory. These
observations have, in turn, led to the
development of detailed mathematical
models of the neural mechanisms under-
lying human cognition and perception
(Gold and Shadlen, 2007; Reynolds and
Heeger, 2009).
Finally, closeparallelsbetween theorga-
nization of the human brain and that of the
nonhuman primate mean that discoveries
made about cognitive mechanisms in one
species candirectly illuminate the homolo-
gous structure in the other. For example,
fMRI studies in humans have mapped out
a network of areas that are involved in the
allocation of attention (Corbetta and Shul-
man, 2002; Yantis and Serences, 2003).
Single-unit recording andmicrostimulation
studies in the macaque have then exam-
ined how feedback signals from these
areas modulate neuronal responses in
visual cortices (Awh et al., 2006).
Although these advances demonstrate
the central importance of the nonhuman
primate as a model organism for human
cognition and perception, we remain
limited in our ability to establish a causal
relationship between the activity of
specific classes of neurons and particu-
lar cognitive and perceptual processes.
These limitations are a consequence of
the fact that the tools available for perturb-
ing primate neural circuits have not, until160 Neuron 62, April 30, 2009 ª2009 Elsevienow, provided a means of targeting
specific classes of neurons for control
with high temporal resolution. For ex-
ample, while microstimulation can be
used to evoke neuronal activity with great
temporal precision, it activates neurons
nonspecifically and can activate fibers of
passage, resulting in activation outside
the area of interest. Pharmacological
agents can locally modulate neurons,
especially when combined with expres-
sion of heterologous receptors using viral
vectors (Tan et al., 2006) and can with the
use of promoters be restricted to a partic-
ular class of neurons. However, they lack
temporal precision and thus cannot be
used to modulate neuronal responses on
the time scale of key cognitive processes,
such as attention,which can shift fromone
object to another in less than a second.
Optogenetic techniques overcome these
limitations. Genetic targeting provides
cell-class specificity. Spatial precision is
achieved by limited spread of the virus
and the narrow focus of the laser source
used toactivateChR2.Temporal precision
is achieved by high temporal resolution of
the laser and the fast kinetics of the ChR2
channel. The successful use of this tech-
nique in a primate means that we can
have our cake and eat it too: we can now
leverage the power of molecular biology
in the non-human primate to dissect the
neural mechanisms of cognitive function.
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